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The 2008 Lasker-Koshland Award will be presented to Stanley Falkow, one of the legendary figures 
in the history of microbiology research. Falkow’s many contributions remade the way we think 
about bacterial pathogens, antibiotic resistance, and infectious disease.The 2008 Lasker-Koshland Special 
Achievement Award in Medical Science 
is to be presented to Stanley Falkow, 
the Cahill Professor of Microbiology 
and Immunology at Stanford University 
School of Medicine. Dr. Falkow has been 
the single most important figure in the 
analysis of bacterial pathogens over the 
past 50 years. His influence has shaped 
several fields of research involving the 
pathogenesis and drug resistance of 
disease-causing bacteria. This influence 
is the result of both breakthrough scien-
tific results and philosophical discourses 
on what constitutes a pathogen. Many of 
the advances associated with his name 
have been completely internalized by 
contemporary microbiologists making 
it easy to forget that these results con-
tradicted the scientific orthodoxy of their 
time. Indeed, very few scientists are 
such obvious choices for an award that 
is meant to be given to “scientists whose 
contributions to research are of unique 
magnitude and have immeasurable influ-
ence on the course of science, health, 
or medicine, and whose professional 
careers have engendered within the bio-
medical community the deepest feelings 
of awe and respect.”
Dr. Falkow’s work has had a major 
impact on the discovery and visualiza-
tion of extrachromosomal DNA in bac-
teria, the mechanism of acquisition of 
simultaneous resistance to multiple anti-
biotics, the mechanism of gene transpo-
sition, and the identification of bacterial 
virulence proteins. He then taught an 
entire field how to identify and analyze 
bacterial proteins that cause disease and 
manipulate host cells. His deep under-standing of infectious diseases, remark-
able for a scientist without a degree in 
medicine, has infiltrated the psyche of an 
entire field—so much so, in fact, that he 
is considered a mentor by virtually every 
researcher trying to understand the 
molecular basis for how bacterial patho-
gens cause disease. He is the direct 
intellectual descendant of the founders 
of microbiology; his impact can only be 
rightly compared to that of the original 
microbe hunters of the late 19th and early 
20th centuries.
Extrachromosomal DNA and 
 Antibiotic Resistance
In the 1950s and early 1960s, investigators 
working on laboratory strains of Escheri-
chia coli dominated the field of bacte-
rial genetics. Genetic evidence had been 
obtained for the existence of extrachromo-
somal elements, such as temperate bacte-
riophages and plasmids, and the analysis 
of these elements allowed the first molec-
ular insights into the mechanisms of DNA 
replication and recombination, as well as 
the identification of the first genetic regula-
tory circuits. Originally called “episomes” 
by Jacob and Wollman, this term eventu-
ally became synonymous with plasmids 
before falling into disuse. The E. coli sex 
factor F was the first plasmid described, 
and its ability to pick up and transfer 
pieces of the bacterial chromosome was 
under intensive study. As plasmid transfer 
was termed conjugation, and sex in higher 
organisms showed strong species barri-
ers, the titillating linguistics describing this 
process seemed to suggest that plasmid 
transfer only occurred between closely 
related bacterial species.Cell 134, SeNo one had directly isolated plas-
mids at that time. Indeed, when Stan-
ley Falkow began studying pathogenic 
Salmonella and Shigella bacterial spe-
cies, it had still not been demonstrated 
that plasmids were composed of DNA. 
Working with Lou Baron at Walter Reed 
Army Institute of Research, Falkow dis-
covered that an F factor containing lac 
chromosomal DNA could be transferred 
to the unrelated Serratia marsescens 
species (Falkow et al., 1961). The sig-
nificance of this heretical observation 
was not lost on Falkow. He was well 
acquainted with recent literature on 
speciation using DNA base content, 
which showed that different species 
had a different guanine-cytosine (G+C) 
base content, allowing separation of 
DNA on cesium chloride (CsCl) gradi-
ents. During a short but productive stint 
in Julius Marmur’s laboratory at Bran-
deis University, Falkow’s discovery that 
the G+C base content of Serratia was 
very different from that of Salmonella 
was an important breakthrough. He 
could separate Salmonella DNA from 
that of Serratia and found that the F 
factor had a buoyant density different 
from that of the DNA of either species 
on CsCl gradients. Plasmids could now 
be isolated, analyzed, and dissected 
for the first time, and indeed they were 
composed of DNA. His observation that 
Proteus mirabilis has a G+C content 
that was even more distinct from that 
of E. coli (38% compared to 50% for E. 
coli) facilitated the next set of experi-
ments that changed forever our percep-
tion of acquired antibiotic resistance in 
bacteria.ptember 19, 2008 ©2008 Elsevier Inc. 907
Falkow was not the only one thinking 
along the lines of interspecies transfer 
of DNA. Watanabe and Fukasawa had 
strong evidence that antibiotic-resis-
tant strains of enterobacteria emerg-
ing in Japanese clinics had resulted 
from the transfer of plasmids, per-
haps from unrelated bacterial species. 
Falkow turned his attention to these 
newly described plasmids, called R fac-
tors, and demonstrated that the same 
techniques used for F factor could be 
used to isolate and characterize antibi-
otic resistance elements (Falkow et al., 
1966). After transferring the resistance 
phenotype from E. coli strains to Pro-
teus, Falkow showed that the resis-
tance factors were plasmids that could 
be clearly visualized as satellite bands 
separate from Proteus chromosomal 
DNA on CsCl gradients. Consistent with 
Watanabe’s observation that resistance 
was lost after treatment with acridine, a 
DNA intercalating reagent that “cured” 
the plasmid, the satellite bands disap-
peared in the presence of the chemical. 
Even more interesting was the nature of 
multiple antibiotic resistance that could 
be transferred between bacterial strains. 
Density gradients of these resistant 
strains sometimes showed multiple sat-
ellite bands or “shoulders” on peaks of 
other DNA species. If spontaneous vari-
ants that had lost one or more antibiotic 
resistance phenotypes were analyzed, 
peaks would lose intensity and the pres-
ence of shoulders would become more 
evident. Therefore, antibiotic resistant 
strains had multiple plasmids conferring 
this resistance. The loss of resistance 
was not due to mutation but was due to 
the spontaneous loss of plasmid DNA 
encoding drug resistance elements. 
Most importantly, the acquisition of 
resistance to multiple drugs was due 
to plasmid transfer between potentially 
unrelated bacterial species. The spread 
of antibiotic resistance was due to the 
promiscuous sexuality of bacteria and 
the transferable R factor plasmids they 
harbored.
It is often difficult to convey to stu-
dents the mysteries leading up to 
results or to frame the importance of 
experiments that appear simple in 
comparison to today’s technology. With 
the discovery of antibiotics, it had been 
thought that all infectious diseases hav-908 Cell 134, September 19, 2008 ©2008 Eling a bacterial cause could be cured 
with chemotherapeutics, and there was 
no reason to discourage unfettered use 
of antibiotics. The development of anti-
biotic-resistant microorganisms may 
have been predicted, but the nature of 
resistance was perceived at that time 
to be the result of spontaneous muta-
tions that eliminated the target sites of 
antibiotics. With the isolation and char-
acterization of R factor DNA by Falkow, 
a new model for antibiotic resistance 
had to be developed. Antibiotic resis-
tance was found on extrachromosomal 
elements, and it was transferable, pro-
miscuous, crossed species barriers, 
and in certain circumstances had vari-
able genetic stability. The most wide-
spread antibiotic use was in livestock 
to “enhance” growth. Falkow realized 
that bacteria harbored by livestock 
were largely antibiotic resistant, and 
as the species barriers for transfer of 
resistance were looser than in higher 
organisms, resistance of pathogens 
to antibiotics could easily be acquired 
from bacteria in livestock (Falkow, 
1970). In addition to the clinical rel-
evance of these findings, the ability 
to easily isolate plasmids that carried 
readily selectable genetic markers, 
such as antibiotic resistance, provided 
a critical first step in the dawning of the 
age of recombinant DNA technology.
What was the nature of the antibiotic 
resistance genes on plasmids? The 
ampicillin resistance gene encodes a 
β-lactamase, and in the early 1970s, the 
technology to identify sequence rela-
tions between regions of DNA required 
using electron microscopy (EM) and 
single-strand specific nucleases to 
map regions of homology (heterodu-
plex mapping), a technique developed 
in Falkow’s laboratory by Jorge Crosa 
(Crosa et al., 1973). Falkow became the 
laboratory’s EM technician, a title he 
has proudly worn throughout his career. 
By 1974, a large number of seemingly 
unrelated plasmids that encoded ampi-
cillin resistance had accumulated in his 
laboratory, and heteroduplex mapping 
indicated that the gene encoding this 
resistance was identical in these other-
wise nonhomologous plasmids. Some 
process had allowed insertion of this 
gene in seemingly random sites in vari-
ous plasmid DNAs. In a breakthrough sevier Inc.study, Jacob and Hedges showed 
that these insertions were due to gene 
transpositions. Very rapidly, Falkow’s 
graduate students Fred Heffron and 
Ron Gill demonstrated that transposons 
encode their own enzymatic machin-
ery for gene movement, and they pro-
vided the key experiments pointing to a 
molecular model for gene transposition 
(Gill et al., 1978). Through the isolation 
of deletion mutants and complementa-
tion analysis, they showed that trans-
position of the ampicillin-resistance 
transposon (now called Tn3) between 
plasmids involved a replication step 
in which the donor and target plas-
mids are fused, generating a duplica-
tion of the transposon at the junctions 
between the fused plasmids. A pro-
tein missing in one of these deletion 
mutants (now called resolvase) prob-
ably resolved this intermediate, com-
pleting the transposition reaction. This 
experiment formed the basis for the 
now famous “Shapiro Model” for gene 
transposition. Interestingly, transpos-
able antibiotic resistance elements of 
this sort would allow Falkow’s labora-
tory to begin to dissect bacterial pro-
teins important for virulence.
Molecular Cloning and Bacterial 
Virulence Proteins
Throughout the course of his studies on 
antibiotic resistance, Falkow never lost 
sight of his original reason for working 
on plasmids. He considered these DNA 
elements tools to perform conjuga-
tion experiments that allowed genetic 
manipulation of bacterial pathogens. 
The problem with this approach was 
that conjugative manipulation of 
genetic markers was not a sufficiently 
powerful tool to allow one to decipher 
what proteins pathogens encode to 
cause disease. For Falkow, therefore, 
plasmids became interesting biologi-
cal entities to study in-and-of them-
selves, while waiting for technology 
that would allow sophisticated analy-
sis of pathogens. His re-entry into the 
world of the microbiology of pathogens 
started slowly, following up on a con-
versation in the late 1960s with veteri-
nary microbiologist H.W. Smith. Smith 
had demonstrated that E. coli strains 
that cause diarrhea in piglets encode 
enterotoxins on conjugative plasmids. 
Nature had “cloned” virulence-asso-
ciated genes, and these could now 
be studied. Unfortunately, these plas-
mids were still rather large entities, and 
there were no genetic tools available 
to allow the same kind of dissection of 
virulence-associated genes that work-
ers had used to analyze regulatory cir-
cuits in the K-12 strain of E. coli. So it 
was with great excitement that Falkow 
participated in the “Delicatessen Dia-
logs” leading to Chang’s, Cohen’s, and 
Boyer’s plan to construct the first syn-
thetic plasmids using restriction endo-
nucleases (Cohen et al., 1973). The 
ability to purify and analyze DNA frag-
ments at will by molecular cloning now 
meant that any gene involved in bac-
terial pathogenesis could be analyzed. 
So, it was not long before Falkow’s 
laboratory became the first to identify 
and clone enterotoxin genes in work 
performed by Magdelene So and Wal-
ter Dallas (Dallas and Falkow, 1979; So 
et al., 1976).
In the late 1970s, the study of bacterial 
pathogenesis was almost totally synony-
mous with the analysis of exotoxins, pro-
teins secreted by bacteria that have tar-
gets either on the surface or within host 
cells. Secondary to toxin analysis was 
the study of bacterial adhesion to host 
cells, which was primarily limited to pili, 
proteinaceous appendages on the sur-
face of Gram-negative organisms. These 
were obvious targets for the first recom-
binant DNA experiments, but the discov-
ery of these determinants relied on their 
purification as biochemical entities prior 
to their genes being isolated. The use of 
wholly genetic approaches to identify 
previously unknown bacterial virulence 
proteins had rarely been attempted in any 
systematic fashion. One such attempt by 
Falkow in the 1960s produced interest-
ing data on the role of lipopolysaccha-
ride (LPS) in establishing disease, but 
there were clearly other determinants 
of virulence that he could not identify. In 
fact, he dropped the traditional genetic 
approach for analyzing pathogenesis 
when he received little encouragement 
from colleagues to continue this avenue 
of attack. Another problem with tradi-
tional genetic techniques was that they 
were limited to microorganisms, such as 
E. coli and Salmonella, that had a long 
history of genetic analysis. But there was a very wide world of bacterial pathogens 
that were medically important that could 
not be studied this way, some of which 
could not even be grown in pure cul-
ture. Once recombinant DNA technol-
ogy and transposable genetic elements 
that could be inserted in a wide range of 
organisms became available, the door 
swung open to allow investigation of 
bacterial pathogens that previously had 
been intractable to genetic analyses.
Through a coalescence of proof-of-
principle and chutzpah, Falkow began 
to work on Yersinia pestis and Bordetella 
pertussis. Y. pestis is an enteric bacte-
rium related to E. coli, so it seemed like a 
small technological step to move to this 
pathogen. But the bug causes bubonic 
plague! This was Falkow’s signal that it 
was time for everyone in the field to think 
about studying the most virulent organ-
isms with the same strategies used to 
study the less dangerous ones. B. per-
tussis, the causative agent of whooping 
cough, was another matter altogether. 
The bacterium grows poorly, there were 
few culture media available that allowed 
reproducible passage, and genetic 
analysis of this microorganism seemed 
hopeless at the time. Fortunately, Falkow 
found two risk-taking PhD candidates 
who rose to the challenge. With Dan 
Portnoy working on Y. pestis and Allison 
Weiss working on B. pertussis, the spec-
trum of bacterial pathogens being stud-
ied in his lab was suddenly very wide.
In quick order, Portnoy demonstrated 
that the critical virulence proteins of Y. 
pestis are encoded on a plasmid, and 
he isolated insertion mutations that led 
to the discovery of a dedicated secretion 
system (now called a Type III system) that 
translocates Yersinia proteins into host 
cells (Portnoy et al., 1983). Furthermore, 
he was able to identify the very proteins 
that were later shown to move into the 
host cell. Working on B. pertussis, Weiss 
first established that transposable anti-
biotic resistance elements could be used 
to dissect this organism genetically and 
then uncovered a new global regulatory 
system that was later shown to involve 
a histidine kinase cascade (Weiss and 
Falkow, 1984). What had previously 
been described as “virulence factors” 
now became real entities in the hands 
of Falkow and coworkers. Although each 
bacterial pathogen has its special chal-Cell 134, Slenges, and many require huge efforts 
to obtain small amounts of instructive 
information, the fear of analyzing these 
agents was gone. Most importantly, 
any kind of genetic screen or selec-
tion seemed within reason, allowing an 
understanding of bacterial pathogenesis 
that had seemed impossible even when 
Falkow was a mid-career scientist.
With this background, Falkow decided 
that it was time to both use the host and 
study it. In part this reflected the interests 
of those attracted to his lab, but it was 
also a direct outgrowth of the new sorts 
of assays being used in his laboratory, 
which allowed analysis of the uptake and 
manipulation of cultured cells. The abil-
ity to identify the important bacterially 
encoded proteins that manipulate target 
cells meant that workers could use bac-
terial proteins to interrogate host cells. 
Using host cells as selective agents, his 
lab was able to identify and analyze bac-
terial proteins that mediate the adhesion 
and uptake of pathogens into host cells 
(Isberg and Falkow, 1985). Furthermore, 
host cells themselves became a new 
growth medium for bacteria. Strategies 
were developed in the lab to identify 
proteins that were selectively expressed 
when bacteria were associated or inter-
nalized into host cells and to analyze the 
impact in animal models of mutations 
that prevented bacteria from making 
these proteins. But what was the host 
doing to either collaborate with or antag-
onize these proteins, both at the cellular 
and organismal levels?
To better appreciate how the patho-
gen causes disease, Falkow’s labora-
tory had to directly analyze the response 
of host cells to the infecting organism. 
This led to the idea that the disease 
process is a result of fine-tuning con-
trasting strategies of stealth, destruc-
tion, and misregulation. Stealth was 
recognized when his group analyzed 
entry of Salmonella into cells overlying 
intestinal lymph nodes or when they 
observed that the microorganism-gen-
erated responses in cultured mamma-
lian cells mimicked the effects of growth 
factors (Jones et al., 1994). Destruction 
could be seen when the same bacteria 
entering lymph nodes also destroyed 
intestinal epithelial cells. Misregula-
tion was documented when his labora-
tory discovered that the CagA protein eptember 19, 2008 ©2008 Elsevier Inc. 909
of Helicobacter pylori, the causative 
agent of gastric ulcers, disrupted epi-
thelial junctions (Figure 1) (Amieva et 
al., 2003).
The Zen of Bacterial Pathogenesis
Listing the accomplishments of Stan-
ley Falkow and his laboratory does not 
reflect the true importance of Falkow 
to the field of microbiology. In part, 
his impact has been amplified by the 
impressive careers of the many stu-
dents and postdoctoral fellows whom 
he trained. Even more striking is his 
role as the premier philosopher-scien-
tist of the field of microbial pathogen-
esis, reflecting his broad knowledge of 
infectious diseases, incredible intuition, 
uncanny ability to understand what the 
next interesting question will be, and 
ability to formulate experiments that 
were often years ahead of the think-
ing of the field. For instance, today 
when the complete genome sequence 
of a pathogen is determined, the first 
order of business is to analyze its G+C 
content, looking for regions that vary 
markedly from the rest of the coding 
sequence. These regions are marked 
as “islands” harboring genes obtained 
by horizontal transfer that may encode 
proteins involved in the pathogenesis 
of disease. This concept of pathogenic-
ity islands is an extension of Falkow’s 
original experiments in the 1960s show-
ing that there were discontinuities in the 
G+C content of F factor DNA, which he 
supposed might be indicators of mobile 
genetic elements.
Finally, an effective scientific leader has 
a flexible attitude toward his own ideas, 
particularly in light of the rapid pace of 
research. Perhaps the treatise that is 
most closely associated with Falkow 
is his “Molecular Koch’s Postulates” 
(Falkow, 1988). This model was meant to 
increase the rigor of the field; he argued 
that if a researcher wants to claim that 910 Cell 134, September 19, 2008 ©2008 Ea protein is involved in the disease pro-
cess, its gene should be knocked out and 
the mutant should be tested in an animal 
model of infection. Only if the mutant 
shows a defect in some process associ-
ated with disease should the researcher 
feel safe in calling it a virulence factor. 
It is a mark of his character as a scien-
tist that he is the one who has published 
the most detailed and scathing critique 
of the shortcomings of this model, in a 
paper that is probably the best summary 
of the complexities inherent in the analy-
sis of pathogens (Falkow, 2004).
The remarkable career of Stanley 
Falkow has forever changed the analy-
sis of bacterial pathogens. His lifelong 
interest in microbes, his ability to strad-
dle the worlds of molecular biology and 
figure 1. A Predator stalks Its Prey
Shown are confocal micrographs of cultured gas-
tric cells challenged with the ulcer-causing bacte-
rium Helicobacter pylori. (Top) When the bacterium 
(green) encounters the host cell, it injects its CagA 
protein (red) into the host cell resulting in altered 
cellular signaling. CagA also colocalizes with the 
host cell junction protein ZO-1 (blue). From Amieva 
et al., Science 300, 1430-1434, 2003. Reprinted 
with permission from AAAS.lsevier Inc.infectious diseases, his enthusiastic 
and charismatic personality that is an 
excellent tool for recruiting talented sci-
entists to the field of microbiology, and 
his amazing ability to see into the future 
put him at a level of accomplishment and 
influence that is rarely encountered in 
any field of research.
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